Funding drives viral challenge agent development forward
CDMO Naobios, a provider of bioprocess development and GMP production of clinical batches of virus-based products, has plans to manufacture a human viral challenge agent for evaluating the effectiveness of vaccines in preventing infections. Click to read more...
Source: labmate-online.com